Relentless Prescription Drug Price Increases-Reference-Cited by-同舟云学术

Relentless Prescription Drug Price Increases

Published:2020-03-03 Issue:9 Volume:323 Page:826
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Deb Chaarushena¹,Curfman Gregory²

Affiliation:

1. Yale Law School, New Haven, Connecticut

2. Deputy Editor, JAMA, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2762290/jama_deb_2020_ed_200005.pdf

Reference13 articles.

1. Lobbying expenditures and campaign contributions by the pharmaceutical and health-product industry in the United States, 1999-2018;Wouters;JAMA Intern Med

2. Innovation in the pharmaceutical industry: new estimates of R&D costs.;DiMasi;J Health Econ,2016

3. The $2.6 billion pill: methodologic and policy considerations.;Avorn;N Engl J Med,2015

4. Estimated research and development investment needed to bring a new medicine to market, 2009-2018;Wouters;JAMA

5. Profitability of large pharmaceutical companies compared with other large public companies;Ledley;JAMA

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment, maintenance and application effect analysis of the prescription pre-review system in a tertiary hospital in china;2023-11-02

2. Changes in Prescription Drug and Health Care Use Over 9 Years After the Large Drug Price Increase for Colchicine;JAMA Internal Medicine;2023-07-01

3. Drug Pricing;Physician Crisis;2023

4. Drug discovery: Chaos can be your friend or your enemy;Managing the Drug Discovery Process;2023

5. Backgrounder—Part 1;Managing the Drug Discovery Process;2023